Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

MYRIAD GENETICS INC Filed Acc 0002012383-26-001053

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2024-11-14 SC 13G/A · GLENVIEW CAPITAL MANAGEMENT, LLC 1.39%
  2. 2024-05-01 SC 13G · Integrated Core Strategies (US) LLC 5.0%
  3. 2024-04-25 SC 13G · Integrated Core Strategies (US) LLC 4.97%
  4. 2024-03-18 SC 13G · Millennium Management LLC 4.7%
  5. 2024-02-14 SC 13G/A · Camber Capital Management LP 8.5%
  6. 2024-02-14 SC 13G/A · GLENVIEW CAPITAL MANAGEMENT, LLC 5.97%
  7. 2024-02-13 SC 13G/A · The Vanguard Group 11.12%
  8. 2024-02-08 SC 13G/A · Wellington Management Group LLP 8.07%
  9. 2024-01-24 SC 13G/A · STATE STREET CORPORATION 5.25%
  10. 2024-01-23 SC 13G/A · Integrated Core Strategies (US) LLC 4.0%
  11. 2024-01-22 SC 13G/A · BlackRock, Inc. 16.6%
  12. 2023-10-17 SC 13G · Millennium Management LLC 5.2%
  13. 2023-03-01 SC 13G · GLENVIEW CAPITAL MANAGEMENT, LLC 5.31%
  14. 2023-02-14 SC 13G/A · Camber Capital Management LP 8.64%
  15. 2023-02-09 SC 13G/A · The Vanguard Group 11.49%
  16. 2023-02-06 SC 13G/A · Wellington Management Group LLP 8.38%
  17. 2023-01-31 SC 13G/A · STATE STREET CORPORATION 6.20%
  18. 2023-01-23 SC 13G/A · BlackRock, Inc. 17.7%
  19. 2023-01-09 SC 13G/A · EARNEST Partners, LLC 4.1%
  20. 2022-05-12 SC 13G · Camber Capital Management LP 5.85%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…